TrialThe lancet. HIV2018

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.

Jean-Michel Molina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.